StreetInsider.com News Articles

Form 4 MCKESSON CORP For: Jun 17 Filed by: TYLER BRIAN S.

Thu, 18 Jun 2026 15:36:00 -0400

si-local-file:///var/storage/secattach/20260618/26665646.html

Form 4 MCKESSON CORP For: Jun 17 Filed by: TYLER BRIAN S.

Thu, 18 Jun 2026 15:36:00 -0400

si-local-file:///var/storage/secattach/20260618/26665646.html

Oral Wegovy reaches 33% of total prescriptions by May

Thu, 18 Jun 2026 05:47:49 -0400

Investing.com -- Oral Wegovy accounted for approximately 33% of total Wegovy prescriptions in May, according to a Bank of America report released Thursday. The oral formulation reached 159,000 weekly total prescriptions in the week ending June 5, 2026.

The oral version of Wegovy launched in early January and has grown rapidly since its introduction. Weekly new prescriptions for oral Wegovy represented 40% of total new Wegovy prescriptions in the week ending June 5, 2026. The mix of oral prescriptions has stabilized in the low-30% range over recent weeks after initial rapid growth.

The broader GLP-1 drug category showed weekly total prescription growth

Oral Wegovy reaches 33% of total prescriptions by May

Thu, 18 Jun 2026 05:47:49 -0400

The broader GLP-1 drug category showed weekly total prescription growth

Oral Wegovy reaches 33% of total prescriptions by May

Thu, 18 Jun 2026 05:47:49 -0400

The broader GLP-1 drug category showed weekly total prescription growth

Oral Wegovy reaches 33% of total prescriptions by May

Thu, 18 Jun 2026 05:47:49 -0400

The broader GLP-1 drug category showed weekly total prescription growth

Oral Wegovy reaches 33% of total prescriptions by May

Thu, 18 Jun 2026 05:47:49 -0400

The broader GLP-1 drug category showed weekly total prescription growth

Form 144 MCKESSON CORP Filed by: TYLER BRIAN S.

Wed, 17 Jun 2026 10:05:00 -0400

si-local-file:///var/storage/secattach/20260617/26658118.html

Form 144 MCKESSON CORP Filed by: TYLER BRIAN S.

Wed, 17 Jun 2026 10:05:00 -0400

si-local-file:///var/storage/secattach/20260617/26658118.html

Form ARS MCKESSON CORP For: Mar 31

Fri, 12 Jun 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260612/26641428.html

Form ARS MCKESSON CORP For: Mar 31

Fri, 12 Jun 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260612/26641428.html

Form DEFA14A MCKESSON CORP

Fri, 12 Jun 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20260612/26641315.html

Form DEFA14A MCKESSON CORP

Fri, 12 Jun 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20260612/26641315.html

Form DEF 14A MCKESSON CORP For: Mar 31

Fri, 12 Jun 2026 16:24:00 -0400

si-local-file:///var/storage/secattach/20260612/26641227.html

Form DEF 14A MCKESSON CORP For: Mar 31

Fri, 12 Jun 2026 16:24:00 -0400

si-local-file:///var/storage/secattach/20260612/26641227.html

McKesson secures $2.25 billion term loan facility due 2032

Fri, 12 Jun 2026 08:06:51 -0400

McKesson Corporation (NYSE: MCK) subsidiaries entered into an amendment on June 9, 2026, to establish a $2.25 billion senior secured term loan facility with a maturity date of 2032, according to a company statement.

The amendment modified an existing credit agreement dated April 1, 2026, with JPMorgan Chase Bank serving as administrative agent and collateral agent. McKesson Medical-Surgical Top Holdings serves as the borrower under the facility.

The term loan carries variable interest rates based on the borrower's selection. The company can choose between the Adjusted Term SOFR Rate plus 2.25% annually or the Base Rate plus 1.25% annually. McKesson initially selected

Form 8-K MCKESSON CORP For: Jun 09

Fri, 12 Jun 2026 08:05:00 -0400

si-local-file:///var/storage/secattach/20260612/26638441.html

Form 8-K MCKESSON CORP For: Jun 09

Fri, 12 Jun 2026 08:05:00 -0400

si-local-file:///var/storage/secattach/20260612/26638441.html

Form 4 MCKESSON CORP For: Jun 09 Filed by: TYLER BRIAN S.

Thu, 11 Jun 2026 10:31:00 -0400

si-local-file:///var/storage/secattach/20260611/26633996.html

Form 4 MCKESSON CORP For: Jun 09 Filed by: TYLER BRIAN S.

Thu, 11 Jun 2026 10:31:00 -0400

si-local-file:///var/storage/secattach/20260611/26633996.html

McKesson (MCK) PT Lowered to $925 at Barclays

Wed, 10 Jun 2026 05:25:42 -0400

Barclays analyst Glen Santangelo lowered the price target on McKesson (NYSE: MCK) to $925.00 (from $1,050.00) while maintaining a Overweight rating.

Form 144 MCKESSON CORP Filed by: TYLER BRIAN S.

Tue, 09 Jun 2026 10:03:00 -0400

si-local-file:///var/storage/secattach/20260609/26621905.html

Form 144 MCKESSON CORP Filed by: TYLER BRIAN S.

Tue, 09 Jun 2026 10:03:00 -0400

si-local-file:///var/storage/secattach/20260609/26621905.html

Form 4 MCKESSON CORP For: Jun 05 Filed by: Rutledge Napoleon B JR

Mon, 08 Jun 2026 14:55:00 -0400

si-local-file:///var/storage/secattach/20260608/26616815.html

Form 4 MCKESSON CORP For: Jun 05 Filed by: Rutledge Napoleon B JR

Mon, 08 Jun 2026 14:55:00 -0400

si-local-file:///var/storage/secattach/20260608/26616815.html